Error: Could not add to watchlist. X

Candriam Equities L Biotechnology

+ Watchlist
DEXLBIC:LX
3,701.34
USD
90.45
2.50%
As of 00:59:30 ET on 08/27/2015.
Fund Type
SICAV
52Wk Range
2,720.10 - 4,236.81
1 Yr Return
25.88%
YTD Return
12.20%
Previous Close
3,610.89
52Wk Range
2,720.10 - 4,236.81
1 Yr Return
25.88%
YTD Return
12.20%
Fund Type
SICAV
Objective
Health Care Sector
Asset Class Focus
Equity
Geographic Focus
International
NAV (on 08/27/2015)
3,701.34
Total Assets (m USD) (on 08/27/2015)
805.113
Inception Date
03/03/2010
Last Dividend (on -)
-
Dividend Indicated Gross Yield
-
Fund Managers
RUDI VAN DEN EYNDE
Front Load Fee
0.00%
Back Load Fee
0.00%
Redemption Fee
0.00%
12b-1 Fee
-
Current Mgmt Fee
0.75%
Expense Ratio
0.66%
Top Fund Holdings
Name Position Value % of Fund
Gilead Sciences Inc 625.00 k 73.18 m 8.59
Biogen Inc 152.50 k 61.60 m 7.23
Amgen Inc 383.00 k 58.80 m 6.90
Regeneron Pharmaceuticals Inc 115.00 k 58.66 m 6.89
Celgene Corp 501.00 k 57.98 m 6.81
Alexion Pharmaceuticals Inc 170.00 k 30.73 m 3.61
Vertex Pharmaceuticals Inc 241.00 k 29.76 m 3.49
BioMarin Pharmaceutical Inc 198.00 k 27.08 m 3.18
Incyte Corp 247.00 k 25.74 m 3.02
Illumina Inc 97.00 k 21.18 m 2.49
Profile
Candriam Equities L - Biotechnology is a SICAV incorporated under the laws of Luxembourg. The Fund's objective is capital appreciation. The Fund invests in global biotechnology stocks. Because the sector is currently experiencing the highest growth in the U.S., at least two-thirds of the Fund's assets will be invested in U.S. biotechnology stocks.
ADDRESS
Candriam Luxembourg
136 route d'Arlon
1150 Luxembourg
PHONE
352-254-3431